Shu‐Ling Yu
Impact in
-
- Viral-associated cancers and disorders
-
- Viral Infections and Immunology Research
Papers in
-
- Viral Infections and Immunology Research 6
-
- Respiratory viral infections research 5
- Co-authors
- Yen‐Hung Chow (13 shared papers)Charles Sia (5 shared papers)Chia‐Chyi Liu (5 shared papers)Kuang-Nan Hsiao (3 shared papers)Jen‐Yang Chen (2 shared papers)Chih‐Yeu Fang (2 shared papers)Ebenezer Chitra (5 shared papers)Pele Choi-Sing Chong (4 shared papers)
- Journals
- PLoS ONE (3 papers)Vaccine (2 papers)Virology (2 papers)Antiviral Research (1 paper)International Journal of Infectious Diseases (1 paper)
- Partner nations
- TaiwanJapanUnited States
In The Last Decade
Shu‐Ling Yu
14 papers receiving 403 citations
Peers
Comparison fields: 5 of 40
- Oncology 128
- Cardiology and Cardiovascular Medicine 132
- Otorhinolaryngology 21
- Infectious Diseases 49
- Epidemiology 62
Countries citing papers authored by Shu‐Ling Yu
This map shows the geographic impact of Shu‐Ling Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Ling Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Ling Yu more than expected).
Fields of papers citing papers by Shu‐Ling Yu
This network shows the impact of papers produced by Shu‐Ling Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Ling Yu. The network helps show where Shu‐Ling Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu‐Ling Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 94 | |
| 2 | 2013 | 93 | |
| 3 | 2014 | 54 | |
| 4 | 2013 | 50 | |
| 5 | 2016 | 22 | |
| 6 | 2018 | 21 | |
| 7 | 2009 | 20 | |
| 8 | 2011 | 15 | |
| 9 | 2009 | 11 | |
| 10 | 2015 | 10 | |
| 11 | 2018 | 8 | |
| 12 | 2019 | 7 | |
| 13 | 2016 | 4 | |
| 14 | 2023 | 1 | |
| 15 | 2025 | 0 |
About Shu‐Ling Yu
Shu‐Ling Yu is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology, Genetics, Infectious Diseases and Oncology, having authored 15 papers that have together received 410 indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (6 papers), Respiratory viral infections research (5 papers), Virus-based gene therapy research (2 papers), Viral-associated cancers and disorders (2 papers), Viral Infections and Outbreaks Research (1 paper), Synthesis and biological activity (1 paper), Evolution and Genetic Dynamics (1 paper) and Infectious Diseases and Mycology (1 paper). The work is most often cited by research in Oncology (128 citations), Cardiology and Cardiovascular Medicine (132 citations), Otorhinolaryngology (21 citations), Infectious Diseases (49 citations) and Epidemiology (62 citations). Shu‐Ling Yu has collaborated with scholars based in Taiwan, Japan and United States. Frequent co-authors include Yen‐Hung Chow, Charles Sia, Chia‐Chyi Liu, Kuang-Nan Hsiao, Jen‐Yang Chen, Chih‐Yeu Fang, Ebenezer Chitra, Pele Choi-Sing Chong, Yi‐Wen Lin and Chung-Chun Wu. Their work appears in journals such as PLoS ONE, Vaccine, Virology, Antiviral Research and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.